Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oberweis Micro-Cap Fund (OBMCX)

18.83
Net Asset Value
+1.02%
1 Day
+9.99%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.71%
Expense Ratio
High
Morningstar Risk Rating™
Investment Objective The investment seeks to maximize capital appreciation. The fund invests, under normal circumstances, at least 80% of its net assets in the securities of very small companies which, at the time of purchase, have a market capitalization of less than or equal to $600 million or are within the range of companies represented in the Russell Micro-Cap Growth Index. It invests principally in the common stocks of companies that the fund's investment adviser believes have the potential for significant long-term growth in market value.

Performance

1 month+0.70% 3 years+21.20%
3 months+8.41% 5 years+15.81%
1 year+10.97% Since inception+9.51%
Data through --

Peer Comparisonvs. Small growth

 OBMCXCategory
Performance 5-yr return+15.81%+17.65%
Expense ratio1.71%1.37%
Risk 5 year sharpe ratio0.921.05
Net assets$28.5M$835.3M
Average market cap$548.3M$2.9B
Average P/E26.728.2
Portfolio turnover141%141%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyOberweis
Fund manager & tenureJames Oberweis / 13 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00

Holdings

U.S. stock95.99%
International stock2.18%
Fixed income1.84%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Hardware 22.00%
Industrial materials 14.68%
Business service 10.58%
Consumer goods 9.74%
Healthcare 8.79%
Top 10 Holdings
Portfolio weighting
THRM Gentherm Inc2.90%
IPHI Inphi Corp2.59%
RUBI Rubicon Project Inc2.35%
BBW Build-A-Bear Workshop Inc2.16%
LGND Ligand Pharmaceuticals Inc2.08%
VASC Vascular Solutions Inc2.01%
-- 2.01%
INGN Inogen Inc1.99%
HQY HealthEquity Inc1.98%
BOFI BofI Holding Inc1.95%